Terms: = Germ cell tumor AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Diagnosis
668 results:
1.
Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
[TBL] [Abstract] [Full Text] [Related]
2. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
4. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract] [Full Text] [Related]
5. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
6. Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management.
Zirem Y; Ledoux L; Roussel L; Maurage CA; Tirilly P; Le Rhun É; Meresse B; Yagnik G; Lim MJ; Rothschild KJ; Duhamel M; Salzet M; Fournier I
Cell Rep Med; 2024 Apr; 5(4):101482. PubMed ID: 38552622
[TBL] [Abstract] [Full Text] [Related]
7. REVOLUMAB: A phase II trial of nivolumab in recurrent idh mutant high-grade gliomas.
Picca A; Touat M; Belin L; Gourmelon C; Harlay V; Cuzzubbo S; Cohen-Jonathan Moyal E; Bronnimann C; Di Stefano AL; Laurent I; Lerond J; Carpentier C; Bielle F; Ducray F; Dehais C;
Eur J Cancer; 2024 May; 202():114034. PubMed ID: 38537315
[TBL] [Abstract] [Full Text] [Related]
8. Intratumoral histological and molecular heterogeneity in an adult diffuse glioma.
Yogaretnam T; Heffernan J; Leung R; Heeney C; Walsh A; Looby S; Caird J; Brett FM
Clin Neuropathol; 2024; 43(2):60-64. PubMed ID: 38495012
[TBL] [Abstract] [Full Text] [Related]
9. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract] [Full Text] [Related]
10. Mechanical characteristics of glioblastoma and peritumoral tumor-free human brain tissue.
Kren J; Skambath I; Kuppler P; Buschschlüter S; Detrez N; Burhan S; Huber R; Brinkmann R; Bonsanto MM
Acta Neurochir (Wien); 2024 Feb; 166(1):102. PubMed ID: 38396016
[TBL] [Abstract] [Full Text] [Related]
11. Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction - single centre experience.
Ma H; Zeng S; Xie D; Zeng W; Huang Y; Mazu L; Zhu N; Yang Z; Chu J; Zhao J
Radiol Oncol; 2024 Mar; 58(1):23-32. PubMed ID: 38378035
[TBL] [Abstract] [Full Text] [Related]
12. Insight into deep learning for glioma idh medical image analysis: A systematic review.
Lv Q; Liu Y; Sun Y; Wu M
Medicine (Baltimore); 2024 Feb; 103(7):e37150. PubMed ID: 38363910
[TBL] [Abstract] [Full Text] [Related]
13. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting idh mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
[TBL] [Abstract] [Full Text] [Related]
14. Distant recurrence in the cerebellar dentate nucleus through the dentato-rubro-thalamo-cortical pathway in supratentorial glioma cases.
Kanamori M; Morishita Y; Shimoda Y; Yamamori E; Sato S; Osada Y; Osawa SI; Shibahara I; Saito R; Sonoda Y; Kumabe T; Endo H
Acta Neurochir (Wien); 2024 Feb; 166(1):83. PubMed ID: 38353806
[TBL] [Abstract] [Full Text] [Related]
15. Computational Pathology for Prediction of Isocitrate Dehydrogenase Gene Mutation from Whole Slide Images in Adult Patients with Diffuse Glioma.
Zhao Y; Wang W; Ji Y; Guo Y; Duan J; Liu X; Yan D; Liang D; Li W; Zhang Z; Li ZC
Am J Pathol; 2024 May; 194(5):747-758. PubMed ID: 38325551
[TBL] [Abstract] [Full Text] [Related]
16. From Trauma to tumor: Exploring Post-Traumatic Brain Injury Glioblastoma Patient Characteristics.
Cuschieri A; Pisani R; Agius S
World Neurosurg; 2024 Apr; 184():175-181. PubMed ID: 38307194
[TBL] [Abstract] [Full Text] [Related]
17. Bilateral thalamic and brainstem anaplastic astrocytoma: A case report.
Zhang H; Zhang P; Nie H; Zhang J; Li J; Lu X; Shen Y
Medicine (Baltimore); 2024 Feb; 103(5):e37136. PubMed ID: 38306557
[TBL] [Abstract] [Full Text] [Related]
18. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
Tanaka T; Tamura R; Takei J; Morimoto Y; Teshigawara A; Yamamoto Y; Imai R; Kuranari Y; Tohmoto K; Hasegawa Y; Akasaki Y; Murayama Y; Miyake K; Sasaki H
J Neurooncol; 2024 Feb; 166(3):557-567. PubMed ID: 38291182
[TBL] [Abstract] [Full Text] [Related]
19. Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
Dasgupta P; Rousseau JF
J Neurooncol; 2024 Feb; 166(3):569-574. PubMed ID: 38286976
[TBL] [Abstract] [Full Text] [Related]
20. GlioPredictor: a deep learning model for identification of high-risk adult idh-mutant glioma towards adjuvant treatment planning.
Zheng S; Rammohan N; Sita T; Teo PT; Wu Y; Lesniak M; Sachdev S; Thomas TO
Sci Rep; 2024 Jan; 14(1):2126. PubMed ID: 38267516
[TBL] [Abstract] [Full Text] [Related]
[Next]